Women over 50 lost 35% more weight with this surprising combo

Дата публикации: 24-03-2026 01:06:37

Postmenopausal women may have a powerful new edge in the battle against weight gain. A Mayo Clinic study found that those using menopausal hormone therapy while taking the obesity drug tirzepatide lost about 35% more weight than those on the drug alone. The findings hint at a surprising synergy between hormones and cutting-edge weight-loss medications, potentially opening the door to more effective, personalized treatments for millions of women facing increased cardiometabolic risks after menopause.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Can hormone therapy improve heart health in menopausal women?	2	7	22-04-2025
2	Different menopausal hormone treatments pose different risks	0	8	28-11-2024
3	Scientists find a way to stop dangerous belly fat as we age	5	7	07-05-2026
4	Got ‘Ozempic Butt’? Fix Your Flat And Flabby Booty With Experimental New Drug	0	0	18-06-2026
5	I lost 4st on Mounjaro, but my once thick and glossy hair was wrecked. I tried expensive shampoos and treatments but nothing worked. Then I started taking this supplement, with a wonder ingredient, and it's transformed my looks	5	6	24-06-2026
6	«Доктор, а если я отменю уколы, весь вес вернется обратно, ...	-1	3	26-06-2026
7	Why heart disease risk in type 2 diabetes looks different for men and women	0	7	04-02-2026
8	This GLP-1 drug may be best for weight loss	0	0	15-06-2026
9	Hormone therapy affects the metabolic health of transgender individuals, study finds	0	7	28-11-2024
10	Eli Lilly's Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity	0	0	31-07-2025

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 2. Информативность: 7. Источник: www.sciencedaily.com.